Although first reported in 1973, immune heparin-induced thrombocytopenia (HIT) remains one of the most frequent and devastating adverse drug reactions encountered by physicians. This thoroughly updated fifth edition from international experts Professors Warkentin and Greinacher is the gold standard for accurate diagnosis and management of this condition. Identifying key signs and symptoms and providing clear intervention strategies--including the use of alternative anticoagulants to manage critical circumstances--this is an essential resource for all clinicians and a "must" for hematology consultants. Heparin-Induced Thrombocytopenia, Fifth Edition explores: Clinical and laboratory studies on HITThe immune basis and pathogenesis, animal models, and laboratory testing for HIT antibodies Clinical features, differential diagnosis, scoring systems, and frequency of HIT in diverse clinical settings, including pediatric patients Evidence-based guidelines for recognition, treatment, and prevention Actions that should and should not be taken after the identification of HITTraditional and novel pharmacotherapies, current dosing guidelines, and the advantages and limitations of alternative anticoagulants Selection criteria from a variety of new treatment options, helping physicians determine which of these agents are safe and effective for their patients


Theodore E. Warkentin, MD, FACP, FRCPC is a professor in the Department of Pathology and Molecular Medicine, and the Department of Medicine, at McMaster University, Canada. Prof. Dr. Andreas Greinacher is professor and head of the Department of Transfusion Medicine and the Hemostasis Service at the Medical School and Hospital of the Ernst-Moritz-Arndt-University Greifswald, CEO and chief of staff of the University Hospital Greifswald, and visiting professor at McMaster University Hamilton, Canada.